According to a special symposium offered in The American Journal of the Medical Sciences.

AJMS summarizes developments related to idiopathic pulmonary fibrosis Idiopathic pulmonary fibrosis is a common and severe lung disease of unknown cause and without proven therapies. But experts are pushing forward in investigating brand-new clues to the development and effective treatment of IPF, according to a special symposium offered in The American Journal of the Medical Sciences , official journal of the Southern Society for Clinical Investigation . The journal is published by Lippincott Williams & Wilkins, a right component of Wolters Kluwer Wellness.Having authors suggest the very best reviewers may therefore seem like a good idea. In the aftermath of the latest scandals involving fake peer reviewers, many journals are determined to carefully turn off the reviewer-recommendation option on their manuscript-submission systems. But that move is probably not enough, as the publisher Hindawi uncovered this past spring. Although Hindawi doesn’t allow authors recommend reviewers for his or her manuscripts, it made a decision to examine the peer-review records for manuscripts submitted in 2013 and 2014 for possible fraud. The peer-review procedure used in Hindawi’s journals depends generally on the expertise of its editorial board members and the guest editors of special issues, who are in charge of supervising the overview of submitted manuscripts.5 Because the peer reviewers selected by the guest editors weren’t subject to any kind of independent verification, editors themselves could undermine the procedure in quite similar way that authors or third-party agencies did elsewhere: by creating fake reviewer identities and addresses that they submitted positive reviews endorsing publication.